Activin and Inhibin

L-JNKI-1 is a cell-permeable peptide inhibitor specific for JNK .Appearance:SolidIC50&amp: Target:JNKIn Vivo:L-JNKI-1 has been shown to effectively inhibit JNK activity in in vivo studies. It is shown that Ang II induces a dose-dependent pressor

L-JNKI-1 is a cell-permeable peptide inhibitor specific for JNK .Appearance:SolidIC50&amp: Target:JNKIn Vivo:L-JNKI-1 has been shown to effectively inhibit JNK activity in in vivo studies. It is shown that Ang II induces a dose-dependent pressor

L-JNKI-1 is a cell-permeable peptide inhibitor specific for JNK .Appearance:SolidIC50&amp: Target:JNKIn Vivo:L-JNKI-1 has been shown to effectively inhibit JNK activity in in vivo studies. It is shown that Ang II induces a dose-dependent pressor

L-Moses (L-45) dihydrochloride is the first potent, selective, and cell-active p300/CBP-associated factor ( PCAF ) bromodomain ( Brd ) inhibitor with a K d of 126 nM.Appearance:SolidIC50&amp: Target:Brd 126 nM (Kd)In Vitro:L-Moses (L-45) disrupts

L-Moses (L-45) dihydrochloride is the first potent, selective, and cell-active p300/CBP-associated factor ( PCAF ) bromodomain ( Brd ) inhibitor with a K d of 126 nM.Appearance:SolidIC50&amp: Target:Brd 126 nM (Kd)In Vitro:L-Moses (L-45) disrupts

L-threo Lysosphingomyelin (d18:1) (L-threo-Sphingosylphosphorylcholine) is an endogenous bioactive sphingolipid. L-threo Lysosphingomyelin (d18:1) is a potent S1P receptor agonist with EC 50 s of 19.3, 131.8, and 313.3 nM for hS1P 1 , hS1P 3 , and

L67 (DNA Ligase Inhibitor) is a competitive DNA ligase inhibitor that effectively inhibits DNA ligases I/III (both IC 50 are 10 μM). L67 (DNA Ligase Inhibitor) can cause nuclear DNA damage by reducing levels of mitochondrial DNA and increasing

L67 (DNA Ligase Inhibitor) is a competitive DNA ligase inhibitor that effectively inhibits DNA ligases I/III (both IC 50 are 10 μM). L67 (DNA Ligase Inhibitor) can cause nuclear DNA damage by reducing levels of mitochondrial DNA and increasing

L67 (DNA Ligase Inhibitor) is a competitive DNA ligase inhibitor that effectively inhibits DNA ligases I/III (both IC 50 are 10 μM). L67 (DNA Ligase Inhibitor) can cause nuclear DNA damage by reducing levels of mitochondrial DNA and increasing

L67 (DNA Ligase Inhibitor) is a competitive DNA ligase inhibitor that effectively inhibits DNA ligases I/III (both IC 50 are 10 μM). L67 (DNA Ligase Inhibitor) can cause nuclear DNA damage by reducing levels of mitochondrial DNA and increasing

L67 (DNA Ligase Inhibitor) is a competitive DNA ligase inhibitor that effectively inhibits DNA ligases I/III (both IC 50 are 10 μM). L67 (DNA Ligase Inhibitor) can cause nuclear DNA damage by reducing levels of mitochondrial DNA and increasing

L82 is a selective and uncompetitive DNA ligase 1 ( DNA Lig1 ) inhibitor (hLig1 IC 50 =12 μM). L82 shows anti-proliferative activity to breast cancer cells.In VitroL82 (0-50 μM: 6 d) shows anti-proliferative activity to breast cancer cells. L82 (50